Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
HAE
#1232
Haemonetics Corporation Common Stock
121.6
3
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-0.38%
Monthly Change
+15.72%
6 month change
+100.69%
Year Change
+137.93%
Previous Close
122.1
0
Open
123.7
7
Low
121.0
5
High
123.7
7
Markets
US Stock Market
Healthcare
Medical Instruments & Supplies
HAE
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
Current
Key stats
Total common shares outstanding
50.95 M
51.28 M
50.54 M
50.84 M
48.04 M
45.45 M
45.5 M
Valuation ratios
Enterprise value
6.33 B
3.77 B
4.67 B
4.94 B
3.97 B
3.47 B
6.44 B
Price to earnings ratio
73.68
75.51
36.96
37.03
19.2
26.8
58.32
Price to sales ratio
6.73
3.28
3.64
3.33
2.37
1.95
4.19
Price to cash flow ratio
53.84
18.91
15.59
23.98
17.74
8.87
17.32
Price to book ratio
8.01
4.35
5.2
4.54
3.93
3.27
1.67
Enterprise value to EBITDA ratio
39.96
20.34
18.57
18.62
11.77
12.95
20.85
Profitability ratios
Return on assets %
0.04
0.02
0.06
0.05
0.07
0.04
0.01
Return on equity %
0.11
0.06
0.14
0.12
0.2
0.12
0.04
Return on invested capital %
26.65
15.1
35.29
31.92
38.22
24.65
8.01
Gross margin %
45.7
50.9
52.63
52.83
55.04
59.04
59.76
Operating margin %
10.31
8.13
13.35
12.6
16.3
11.75
16.93
EBITDA margin %
18.21
18.64
21.5
20.26
24.8
20.12
24.94
Net margin %
9.13
4.37
9.87
8.98
12.32
7.29
9.73
Liquidity ratios
Quick ratio
1.46
1.05
2.03
1.5
0.99
1.87
1.91
Current ratio
2.74
1.71
3.06
2.56
1.62
2.95
3.08
Inventory turnover
1.59
1.58
2
2.14
1.79
1.78
0.45
Asset turnover
0.56
0.54
0.62
0.63
0.59
0.56
0.14
Solvency ratios
Debt to assets ratio
0.38
0.3
0.39
0.36
0.38
0.51
0.5
Debt to equity ratio
0.94
0.75
0.92
0.83
1.12
1.53
1.4
Long term debt to total assets ratio
0.44
0.42
0.4
0.45
0.51
0.52
0.5
Long term debt to total equity ratio
1.1
1.05
0.95
1.03
1.52
1.56
1.42
Per share metrics
Operating cash flow per share
2.12
3.35
5.31
3.54
3.58
6.19
6.97
EBIT per share
1.75
1.57
3.03
3.21
4.37
3.31
3.43
EBITDA per share
3.09
3.61
4.89
5.16
6.65
5.67
6.59
Total debt per share
13.46
10.89
14.67
15.52
24.14
25.75
25.69
Cash per share
3.75
5.05
5.53
3.48
6.05
5.18
4.89
Net current asset value per share
13.52
14.72
14.97
14.96
18.43
17.63
17.74
Tangible book value per share
14.26
14.59
15.91
18.68
16.18
-6.5
-5.56
Working capital per share
8.58
6.11
10.07
9.12
7.03
11.66
11.98
Book value per share
14.26
14.59
15.91
18.68
16.18
16.82
18.32
News
Why Haemonetics (HAE) is a Top Momentum Stock for the Long-Term
Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $140
Mizuho Maintains Outperform on Haemonetics, Raises Price Target to $140
Haemonetics: CSL Plasma Improves The Outlook, Not The Entry Point (Rating Downgrade)
Strength Seen in Haemonetics (HAE): Can Its 17.5% Jump Turn into More Strength?
Broader Market Settles Lower on Soaring Crude Prices and Chipmaker Weakness
BTIG Maintains Buy on Haemonetics, Raises Price Target to $130
12 Health Care Stocks Moving In Thursday's Intraday Session
Haemonetics Stock Hits 52-Week High - Here's Why
Stocks Pressured by Soaring Crude Oil Prices
Why Is Haemonetics Stock (HAE) Up Over 13% Today? - TipRanks.com
Stocks Slide as Soaring Crude Prices Boost Inflation Risks